We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
BIOHK2023 is an unparalleled event covering the most relevant and timely topics in biotechnology, from infectious diseases to the latest cancer treatments and diagnostics to big data analytics. During this event biotech specialists will get infinite possibilities to connect with partners not only in Asia but from around the world.
At this event, taking place in Hong Kong on 13-16 September 2023, OCT Clinical will be represented by Business Development Associate, Polina Nabieva. To book a meeting, please contact Polina at pnabieva@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.